Patents
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2007
03/07/2007EP1758874A1 Substituted thiazoleacetic acids as crth2 ligands
03/07/2007EP1758873A1 Ubiquitin ligase inhibitors
03/07/2007EP1758864A1 Substituted tetrahydro-2h-isoquinolin-1-one derivatives, method for the production thereof, and use of the same as medicaments
03/07/2007EP1758862A1 Aminopyridine derivatives as selective dopamine d3 agonists
03/07/2007EP1758860A1 Saturated and unsaturated 3-pyridyl-benzocycloalkylmethyl-amines for use in the treatment of pains, depressions and anxiety states
03/07/2007EP1758857A1 Indole derivatives as antiviral agents
03/07/2007EP1440066B1 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
03/07/2007EP0959076B1 Heteroarylperidines and piperazines and their use as antipsychotics and analgetics
03/07/2007CN1926136A Amino cyclopropane carboxamide derivatives as bradykinin antagonists
03/07/2007CN1926134A 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/07/2007CN1926133A Epothilone derivatives
03/07/2007CN1926129A Novel insecticides
03/07/2007CN1926127A Novel 2-heteroaryl-substituted benzimidazole derivative
03/07/2007CN1926121A Thiazole derivatives and use thereof
03/07/2007CN1926110A Novel heterocyclyl-substituted hydroxy-6-phenylphenanthridines and their use as PDE4 inhibitors
03/07/2007CN1926106A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/07/2007CN1926105A Diarylmethylidene piperidine derivatives, preparations thereof and uses thereof
03/07/2007CN1925854A Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
03/07/2007CN1923820A Novel carboxylic acid derivatives, their preparation and use
03/07/2007CN1923812A New compounds
03/07/2007CN1303074C Heteroaryl alkyl piperazine derivatives as fatty acid oxidation inhibitors
03/07/2007CN1303067C Spiroheterocyclic nitriles useful as reversible inhibitors of cysteine proteases
03/07/2007CN1303066C 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses
03/06/2007US7186849 C7 ester substituted taxanes
03/06/2007US7186843 Aminomethylpyrrolidine derivatives having aromatic substituents
03/06/2007US7186841 Antiinflammation agents
03/06/2007US7186834 Substituted iminoazines
03/06/2007US7186829 Aryl-substituted heterocyclic enaminones
03/06/2007US7186752 Derivatives of N-(iminomethyl)amines, their preparation, their use as medicaments and the pharmaceutical compositions containing them
03/06/2007US7186747 enzyme inhibitors comprising heterocyclic amides, used for prevention of viral diseases
03/06/2007US7186743 drugs such as 1 -[4-(aminosulfonyl)phenyl]-8-{[(trifluoromethyl)sulfonyl]amino}-4,5-dihydro-1H-benzo[g]indazole-3-carboxamide, used as antiinflammatory agents, antiarthritic agents, antipyretics or analgesics
03/06/2007US7186734 Binding to antagonist or inverse antagonist as antiinflammatory agentsand immunological disorders
03/06/2007US7186733 4-(phenyl-(piperidin-4yl)-amino)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
03/06/2007US7186724 central nervous system disorders; psychological disorders; Parkinson's disease; Huntington's disease ; sleep disorders
03/06/2007US7186723 Tyrosine kinase inhibitors
03/06/2007US7186719 Antibacterial agents
03/06/2007US7186718 For therapy of autoimmune, inflammatory, proliferative and hyperproliferative diseases and immunologically-mediated diseases including rejection of transplanted organs or tissues and Acquired Immunodeficiency Syndrome (AIDS
03/06/2007US7186717 Pyrrolidine derivatives as Factor Xa inhibitors
03/06/2007US7186715 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
03/06/2007US7186710 PDE4/7 inhibitors useful in treatment of airway disorders, autoimmune system disorders, skin disorders, arthritis, nerve system disorders
03/06/2007US7186709 Subjecting a vinyl ethers and an unsaturated ketoester to suitable conditions to generate a scaffold having the core dihydropyrancarboxamide or dihydropyrancarboxylic ester or acid; anticarcinogenic agents
03/01/2007WO2007024922A1 Immunosuppressant compounds and compositions
03/01/2007WO2007024754A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseaes
03/01/2007WO2007023882A1 Derivative having ppar agonistic activity
03/01/2007WO2007023507A2 Oxazolidinones bearing antimicrobial activity composition and methods of preparation
03/01/2007WO2007023245A1 Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
03/01/2007WO2007023186A1 Pyrazine derivatives and use as pi3k inhibitors
03/01/2007WO2007023143A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
03/01/2007WO2007022638A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
03/01/2007WO2007003961A3 Gpcr agonists
03/01/2007WO2007002637B1 N-linked heterocyclic antagonists of p2y1 receptor useful in the treatment of thrombotic conditions
03/01/2007WO2007002181A3 Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
03/01/2007WO2006130493A3 Heterocycles useful as modulators of ion channels
03/01/2007WO2006128688B1 Process for the preparation of pramipexole
03/01/2007WO2006036994A3 Modulators of crth2, cox-2 and faah
03/01/2007WO2005117882A9 Hydroxamic acid derivatives as metalloprotease inhibitors
03/01/2007US20070049751 5-(5-iodo-2-isopropyl-4-methoxy-phenoxy)-pyrimidine-2,4-diamine; using iodine monchloride for iodination, cyanoalkylation, hdyrogenation, cyclization; chemical intermediates; using guanidine carbonate, Brederick's reagent and aniline reagent
03/01/2007US20070049623 1-(Hetero)aryl- and 3-substituted with a group containing an arylaldehyde oxime, e.g., 4-[5-(2-oxo-3-pyridin-4-yl-imidazolidin-1-yl)-pentyloxy]-benzaldehyde O-methyl-oxime; treating enteroviral infections
03/01/2007US20070049619 e.g. 3-((S)-2-amino-2-{trans-4-[4-(5-cyano-2-pyridinyl)-1-piperazinyl]-1-cyclohexyl}acetyl)-1,3-thiazolidine; dipeptidyl-peptidases inhibitor; suppress cleavage of glucagon-like peptides (GLP-1) by inhibition of DPP-IV; antidiabetic agent; obesity, non insulin-dependent diabetes
03/01/2007US20070049611 Phosphodiesterase 4 inhibitors
03/01/2007US20070049594 Novel compounds and compositions as cathepsin inhibitors
03/01/2007US20070049584 Antiinflammatory agents, antidepressants, analgesics, purinergic receptor antagonists; neurodegenerative diseases, spinal cord injuries; 1-(2,3-dichlorophenyl)-N-[(2-methylphenyl)methyl]-1H-tetraazol-5-amine
03/01/2007US20070049582 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression
03/01/2007US20070049580 Anxiolytic agents with reduced sedative and ataxic effects
03/01/2007US20070049577 CGRP antagonists
03/01/2007US20070049570 Quinoline derivatives as phosphodiesterase inhibitors
03/01/2007US20070049536 3-Azabicyclo[3.1.0]hexane-amide derivatives; human T-cell leukemia/lymphoma and lymphadenopathy associated virus, AIDS, cytomegalovirus (CMV) and Epstein-Barr virus (EBV), liver disease such as alcoholism and primary biliar cirrhosis
03/01/2007US20070049495 1-Methyl, 3-trifluoromethyl,4-(2-(4-(tert-butylpyrazol-1-yl),2-cyano,1-tert-butylcarbonyloxy)ethylene)-pyrazole; agriculture; preventing the attachment of aquatic organisms to boats, construction materials, heat excangers; coolants; water supply systems; engineering plants; reservoirs; marine/underwater
03/01/2007CA2621164A1 Derivative having ppar agonistic activity
03/01/2007CA2620414A1 Benzodiazepine and benzopiperazine analog inhibitors of histone deacetylase
03/01/2007CA2620173A1 Alpha2c adrenoreceptor agonists
03/01/2007CA2619366A1 Bis-aryl urea compounds for the treatment of protein kinase-mediated diseases
03/01/2007CA2619101A1 Immunosuppressant compounds and compositions
03/01/2007CA2619038A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
03/01/2007CA2618479A1 Pyrazine derivatives and use as pi3k inhibitors
02/2007
02/28/2007EP1757603A1 Therapeutic agent for keratoconjunctiva disorder
02/28/2007EP1757602A1 Vla-4 inhibitor
02/28/2007EP1757599A1 Indole derivatives having piperidine rings
02/28/2007EP1757591A1 Cinnamide compound
02/28/2007EP1757582A1 Arylalkylamines and process for production thereof
02/28/2007EP1757292A1 Method of treating ocd and tic disorders
02/28/2007EP1756100A1 Salt of phosphoric acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)-ethoxy] benzy] thiazolidin-2,4-dione and a method of its preparation
02/28/2007EP1756099A1 Synthesis of antidiabetic rosiglitazone derivatives
02/28/2007EP1756098A2 2-substituted-4-heteroaryl-pyrimidines useful for the treatment of proliferative disorders
02/28/2007EP1756096A1 Indolyl derivatives as liver-x-receptor modulators
02/28/2007EP1756089A1 Mercaptoimidazoles as ccr2 receptor antagonists
02/28/2007EP1756088A1 Quinazoline derivatives as erbb receptor tyrosine kinases
02/28/2007EP1756084A2 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/28/2007EP1756082A1 5-morpholinylmethylthiophenyl pharmaceutial compounds as p38 map kinase modulators
02/28/2007EP1756076A1 Hetroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
02/28/2007EP1756074A1 1,2,4-oxadiazole derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
02/28/2007EP1756063A1 Amido compounds and their use as pharmaceuticals
02/28/2007EP1755613A2 Substituted cyclic urea derivatives
02/28/2007EP1755601A2 Inhibitors of histone deacetylase
02/28/2007EP1507776B1 2-oxo-1,3,4-trihydroquinazolinyl derivatives for the treatment of cell proliferation-related disorders
02/28/2007EP1458703B1 Isochroman compounds for treatment of cns disorders
02/28/2007EP1441734B1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
02/28/2007EP1415987B1 Nitrogenous aromatic ring compounds as anti cancer agents
02/28/2007EP1397350B1 Isoquinolinone derivatives as parp inhibitors
02/28/2007EP1387843B1 Method for obtaining pioglitazone as an antidiabetic agent